Code & Co. advises Investcorp on the acquisition of a majority stake in Cambio Healthcare Systems
Code & Co. advised Investcorp on the technology & product due diligence of Cambio Healthcare System AB, a leading Swedish-based provider of Electronic Health Record (HER) software and services as well as E-Health.
Tech & Product Due Diligence
E-Health & MedTech
Founded in 1993, Cambio operates in the Electronic Health Records (“EHR") market, offering software solutions for acute, primary, social and person-centered care. Cambio promotes a holistic view on health and social care and offers an EHR agnostic solution for clinical decision support applicable for all branches of health and social care. The Company, which has grown rapidly in recent years, has customers primarily in Sweden, Denmark, and the United Kingdom, with more than 150,000 users of its software solutions. Cambio is headquartered in Stockholm, Sweden, and has approximately 600 employees, of which the majority are dedicated to research and development as well as software maintenance.
Investcorp is a leading global provider and manager of alternative investment products.
Daniel Lopez-Cruz, Head of Investcorp’s European Private Equity group, said; “The EHR software market is growing rapidly as hospitals constantly seek to increase the efficiency of their operations and ultimately the quality of their care. Cambio is a strong player in the Nordic market with leading EHR software as well as other competitive E-Health solutions that have the potential to grow beyond its core regional markets. We look forward to working with Cambio’s founders and its exceptional management team as the business expands in the Nordic countries and other international markets.“
The transaction underlines Code & Co.'s position as a market-leading technology and product advisor on private equity mandates to clients across Europe. It further highlights Code & Co.’s extensive technology and product expertise in various sectors of the global digital economy.
Code & Co. is an independent advisory firm specialized in advising funds in the global alternative investment industry. Our expertise is modern and holistic technology and product due diligence. From outside-in audits and confirmatory due diligence to portfolio audits, exit preparation, and vendor due diligence, we provide our clients with crucial insight across the entire investment life cycle.